|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Pindolol#Pharmacology]] |
| {{Pindolol}}
| |
| {{CMG}}
| |
| | |
| ==Description==
| |
| | |
| Visken® (pindolol), a synthetic beta-adrenergic receptor blocking agent with intrinsic sympathomimetic activity is 1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol.
| |
| | |
| Its structural formula is:
| |
| | |
| {|
| |
| | [[File:Pin02.png|800px|thumb]]
| |
| |}
| |
| | |
| Pindolol is a white to off-white odorless powder soluble in organic solvents and aqueous acids. Visken® (pindolol) is intended for oral administration. | |
| | |
| 5 mg and 10 mg Tablets
| |
| | |
| Active Ingredient: pindolol
| |
| | |
| Inactive Ingredients: colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose, and pregelatinized starch.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VISKEN (PINDOLOL) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07fe9cc3-1ef2-420c-b45d-7f1e894b6ef9 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Beta blockers]]
| |
| [[Category:Drugs]]
| |